from
An expert panel of the Drugs Controller General of India has allowed Bharat Biotech to administer the third dose of Covaxin to some of the volunteers in its ongoing clinical trials of the Covid vaccine. The approval would allow it to test the ability of Covaxin to prompt an immune response that could last a … Continue reading "Covaxin: Third dose gets approved for trials"
The post Covaxin: Third dose gets approved for trials appeared first on Gulistan News.
https://ift.tt/2R0boAdvia IFTTT
0 Comments